Armstrong Shaw Associates Decreased By $4.07 Million Its Cvs Health Corp. (CVS) Holding; Wafra Investment Advisory Group Lifted By $1.20 Million Its Pulte Homes (PHM) Position

November 15, 2017 - By Hazel Jackson

Armstrong Shaw Associates Inc decreased Cvs Health Corp. (CVS) stake by 35.4% reported in 2017Q2 SEC filing. Armstrong Shaw Associates Inc sold 50,823 shares as Cvs Health Corp. (CVS)’s stock declined 4.23%. The Armstrong Shaw Associates Inc holds 92,738 shares with $7.46M value, down from 143,561 last quarter. Cvs Health Corp. now has $71.36B valuation. The stock decreased 1.40% or $1 during the last trading session, reaching $70.44. About shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since November 15, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Wafra Investment Advisory Group Inc increased Pulte Homes Inc. (PHM) stake by 7.88% reported in 2017Q2 SEC filing. Wafra Investment Advisory Group Inc acquired 50,127 shares as Pulte Homes Inc. (PHM)’s stock rose 8.08%. The Wafra Investment Advisory Group Inc holds 685,902 shares with $16.83 million value, up from 635,775 last quarter. Pulte Homes Inc. now has $9.34B valuation. The stock increased 0.70% or $0.22 during the last trading session, reaching $31.77. About shares traded. PulteGroup, Inc. (NYSE:PHM) has risen 30.02% since November 15, 2016 and is uptrending. It has outperformed by 13.32% the S&P500.

Among 21 analysts covering PulteGroup (NYSE:PHM), 7 have Buy rating, 2 Sell and 12 Hold. Therefore 33% are positive. PulteGroup had 56 analyst reports since September 11, 2015 according to SRatingsIntel. The firm has “Mkt Perform” rating by FBR Capital given on Friday, October 21. The firm earned “Neutral” rating on Friday, September 11 by JP Morgan. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, July 22 report. Zelman downgraded the stock to “Hold” rating in Monday, April 4 report. The firm has “Buy” rating by RBC Capital Markets given on Monday, June 19. Morgan Stanley downgraded the stock to “Underweight” rating in Tuesday, October 13 report. The firm has “Market Perform” rating by Raymond James given on Monday, April 25. The firm earned “Neutral” rating on Tuesday, December 22 by Sterne Agee CRT. RBC Capital Markets maintained it with “Outperform” rating and $24 target in Friday, January 27 report. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, October 25.

Investors sentiment decreased to 0.91 in 2017 Q2. Its down 0.31, from 1.22 in 2017Q1. It dropped, as 35 investors sold PHM shares while 170 reduced holdings. 56 funds opened positions while 130 raised stakes. 249.89 million shares or 6.67% less from 267.74 million shares in 2017Q1 were reported. Driehaus Mgmt Ltd Liability Corp owns 67,540 shares for 0.06% of their portfolio. Nomura Asset Ltd has 0.01% invested in PulteGroup, Inc. (NYSE:PHM) for 36,983 shares. Moreover, Shell Asset Mgmt has 0.01% invested in PulteGroup, Inc. (NYSE:PHM). Glg Ltd holds 21,367 shares. 176,949 are held by Chase Invest Counsel Corp. 22,850 are owned by Hartwell J M Lp. 175,000 were reported by Claar Advisors Llc. World Asset Mngmt has invested 0.02% in PulteGroup, Inc. (NYSE:PHM). Raymond James Fincl Ser Advsrs Inc invested in 13,246 shares or 0% of the stock. Manufacturers Life Insurance Commerce The invested 0.01% of its portfolio in PulteGroup, Inc. (NYSE:PHM). Northcoast Asset Lc invested 0.25% in PulteGroup, Inc. (NYSE:PHM). Northwestern Mutual Wealth Mgmt Communications has 6,845 shares. Signalpoint Asset Mngmt Ltd Co reported 29,253 shares or 0.2% of all its holdings. 64,630 were accumulated by Mirae Asset Global Investments Co Limited. Moreover, State Of Tennessee Treasury Department has 0.06% invested in PulteGroup, Inc. (NYSE:PHM) for 479,265 shares.

Since June 6, 2017, it had 0 insider purchases, and 1 insider sale for $324,520 activity. 14,000 shares were sold by ANDERSON BRIAN P, worth $324,520.

Wafra Investment Advisory Group Inc decreased Wal (NYSE:WMT) stake by 135,179 shares to 4,896 valued at $371,000 in 2017Q2. It also reduced Rockwell Automation (NYSE:ROK) stake by 3,216 shares and now owns 103,362 shares. Spdr S&P 500 Etf Trust (SPY) was reduced too.

Investors sentiment decreased to 0.92 in 2017 Q2. Its down 0.17, from 1.09 in 2017Q1. It dropped, as 84 investors sold CVS shares while 559 reduced holdings. 108 funds opened positions while 483 raised stakes. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. First National Bank Of Mount Dora Tru Services invested 1.77% in CVS Health Corp (NYSE:CVS). Iberiabank invested 0.33% in CVS Health Corp (NYSE:CVS). Confluence Wealth Management Ltd stated it has 7,777 shares or 0.3% of all its holdings. Quantitative Systematic Strategies Ltd Liability Com invested 0.19% in CVS Health Corp (NYSE:CVS). Greenleaf holds 5,058 shares or 0.01% of its portfolio. Pitcairn owns 9,321 shares. Virginia Retirement Et Al has invested 0.34% of its portfolio in CVS Health Corp (NYSE:CVS). The Michigan-based Columbia Asset Mgmt has invested 0.22% in CVS Health Corp (NYSE:CVS). Qci Asset Management has invested 0.01% of its portfolio in CVS Health Corp (NYSE:CVS). Tower Bridge Advisors has invested 0% in CVS Health Corp (NYSE:CVS). Rwc Asset Management Llp holds 130,654 shares. Badgley Phelps & Bell Inc holds 0.66% or 105,627 shares in its portfolio. Aviance Cap Ltd invested in 0.01% or 1,053 shares. Thornburg Invest invested in 3.22M shares. Gargoyle Invest Advisor Limited Liability Company owns 0.92% invested in CVS Health Corp (NYSE:CVS) for 29,036 shares.

Among 24 analysts covering CVS Health (NYSE:CVS), 15 have Buy rating, 0 Sell and 9 Hold. Therefore 63% are positive. CVS Health has $132 highest and $73 lowest target. $97.85’s average target is 38.91% above currents $70.44 stock price. CVS Health had 52 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, December 12 by Jefferies. The rating was maintained by Jefferies with “Hold” on Wednesday, October 18. Jefferies maintained CVS Health Corp (NYSE:CVS) on Tuesday, November 7 with “Hold” rating. On Monday, November 2 the stock rating was maintained by S&P Research with “Strong Buy”. The firm earned “Hold” rating on Friday, September 8 by Needham. The stock of CVS Health Corp (NYSE:CVS) has “Outperform” rating given on Friday, August 28 by Oppenheimer. The rating was downgraded by Atlantic Securities on Monday, February 6 to “Neutral”. The rating was downgraded by Goldman Sachs on Thursday, December 17 to “Neutral”. The company was maintained on Friday, October 27 by Robert W. Baird. The company was maintained on Tuesday, June 13 by Cowen & Co.

Since June 12, 2017, it had 0 insider purchases, and 1 insider sale for $18.44 million activity. The insider Denton David M sold 230,510 shares worth $18.44M.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on February, 8. They expect $1.90 EPS, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92B for 9.27 P/E if the $1.90 EPS becomes a reality. After $1.50 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>